Technology News and Research

RSS

Automated eye tests best for toddlers

Children under the age of 4 years benefit from instrument-based vision screening rather than visual acuity tests since the former is quick, requires minimal cooperation of the child, and is not dependent on their behavioral responses, says a policy statement released by the American Academy of Pediatrics.

9 Nov 2012

Semprus BioSciences to develop surface-modified endotracheal tube

Teleflex Incorporated, a leading global provider of medical devices for critical care and surgery, has announced that Semprus BioSciences, a wholly owned subsidiary of Teleflex Incorporated, has been awarded the initial phase of a $2.3 million research grant from the U.S. Army's Telemedicine and Advanced Technology Research Center (TATRC), located at Fort Detrick, MD.

9 Nov 2012

Boehner, Obama signal willingness to work together on fiscal crisis

The House speaker says he would accept a deal that raises federal revenues, but not the top tax rates, if it also includes an overhaul of entitlement programs, such as Medicare and Medicaid.

9 Nov 2012

Smoking and smartphones: an interview with Nasser Bin Dhim, Becky Freeman and Lyndal Trevena

Australia adopted the WHO Framework Convention on Tobacco Control (WHO FCTC) in 2005. This includes a ban on all forms of tobacco advertising including on the internet.

9 Nov 2012

ACT announces results from three ongoing stem cell clinical trials for macular degeneration

Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today that its upcoming conference call on its third quarter financial results will also provide some representative examples of data being collected from patients in its clinical trials for forms of macular degeneration.

9 Nov 2012

New method can help identify smoke-divers in danger

Smoke-divers are exposed to high temperatures, physical exhaustion and stress, and they can easily exceed the limits of what good health can tolerate. A new method based on measurements made by a wireless sensor system lets them know when the body has had enough.

9 Nov 2012

Teleconcussion for diagnosis and management of mild TBI in athletes

Concussion is a common disorder estimated to affect no fewer than 1.7-3.8 million people in the U.S. each year. Many more people with concussion likely do not seek medical care for symptoms of concussion and may suffer long-lasting, progressive, and profoundcognitive, psychiatric, and neurologic effects.

9 Nov 2012

Immunomic Therapeutics initiates JRC-LAMP-vax vaccine Phase I trial in Sugi allergy

Immunomic Therapeutics, Inc., a leader in developing novel allergy immunotherapies, announced today that it has dosed the first patient in a Phase I clinical trial of its lead candidate, JRC-LAMP-vax vaccine, at its clinical site in Honolulu, Hawaii. Initial subjects include Japanese ex-patriates previously exposed to Japanese red cedar, or "Sugi," as it is known in Japan.

9 Nov 2012

Regenstrief Institute and Merck sign five-year collaboration agreement

The Regenstrief Institute and Merck, known as MSD outside the United States and Canada, have signed a five-year agreement to collaborate on a range of projects that will use clinical data to inform personalized delivery of health care.

9 Nov 2012

New England Journal of Medicine publishes BMC's capnography training video

Physicians at Boston Medical Center (BMC) have developed a training video for health care providers about how to effectively use capnography to monitor ventilation and carbon dioxide levels for patients under anesthesia or conscious sedation. This is the sixth video published in the New England Journal of Medicine's Videos in Clinical Medicine section produced by BMC. It highlights the importance of using capnography to increase patient safety.

9 Nov 2012

Avinger receives FDA clearance for Ocelot System

Avinger, Inc., a medical device manufacturer of innovative, multi-functional catheters for crossing chronic total occlusions (CTOs) in patients with Peripheral Artery Disease (PAD), announces its Ocelot System has been cleared for sale in the U.S. by the Food and Drug Administration (FDA).

9 Nov 2012

Mayo Clinic receives FDA approval for Choline C 11 Injection to help detect prostate cancer

Mayo Clinic has received U.S. Food and Drug Administration approval to produce and administer Choline C 11 Injection, an imaging agent used during a positron emission tomography (PET) scan to help detect sites of recurrent prostate cancer. Mayo Clinic is the first, and currently only, institution in North America approved to produce this imaging agent.

9 Nov 2012

Pevion launches Defensomes platform for broad spectrum immune enhancement

Pevion Biotech AG today announced the launch of a new program called Defensomes, a platform for broad spectrum immune enhancement via mechanisms of innate immunity. The proprietary technology is derived from a vaccine platform with a solid safety track record comprising more than 80 million doses applied to humans to date. Defensomes offer opportunities for a wide range of prophylactic and therapeutic indications, where boosting of the body's own natural defense is beneficial.

8 Nov 2012

FDA grants Albireo's A4250 orphan-drug designation for treatment of PFIC and PBC

Albireo AB, a biopharmaceutical company specializing in gastroenterology, today announced that A4250 (an inhibitor of the ileal bile acid transporter, IBAT/ASBT) has been granted orphan-drug designation by the U.S Food and Drug Administration for the treatment of Progressive Familial Intrahepatic Cholestasis (PFIC) and Primary Biliary Cirrhosis (PBC).

8 Nov 2012

ACS Prized Science video features advances in personalized medicine

Personalized medicine - the promise of customizing treatments that will work best for each individual patient - could get a boost from advances in understanding how the proteins that help determine health and disease take the three-dimensional shapes needed to work in the body. That's the message of the latest episode of the 2012 edition of a popular video series from the American Chemical Society (ACS), the world's largest scientific society.

8 Nov 2012

NYU-Poly professor selected to participate in 2012 National Academies Keck Futures Initiative conference

Polytechnic Institute of NYU (NYU-Poly) Assistant Professor of Technology Management Oded Nov has been selected to participate in the 2012 National Academies Keck Futures Initiative (NAKFI) conference, a prestigious think-tank-style gathering of researchers in science, engineering and medicine. Nov will join 100 colleagues for the conference, "The Informed Brain in a Digital World."

8 Nov 2012

University of Tübingen heads Neuromics consortium

Work has begun on Neuromics, a major project headed by Tübingen's Professor Olaf Riess; the project beat out ten other first-class applications to attain €12m euros in EU funding over five years.

8 Nov 2012

Radiopharmaceutical Tektrotyd continues to receive interest and recognition

Physicians - attendees of the 25th Annual EANM (European Association of Nuclear Medicine) Congress (October 27-31, Milan) - expressed their continuing interest in and recognition for Tektrotyd, a radiopharmaceutical responsible for significant progress in diagnostics/therapy of neuroendocrine tumours.

8 Nov 2012

U-M to improve disease diagnosis through metabolic profiling

The University of Michigan Health System has earned a $9.1 million core grant from the National Institutes of Health to improve disease diagnosis through metabolic profiling.

8 Nov 2012

Two new EU Member States now represented within TRANSVAC services platform

In addition to the initial panel of nine services, the TRANSVAC transnational access platform has integrated in July 2012 five additional groups which provide their services to users on a free and paid basis. Two new European Union (EU) Member States are now represented within the platform of services: France and Portugal.

8 Nov 2012